We present the creation of wearable devices that measure transcutaneous partial oxygen or carbon dioxide pressure (tcpO2 or tcpCO2) non-invasively. The devices are highly sensitive to the physiological pO2/pCO2, and detects changes in luminescence (lifetime or ratiometric brightness) of mellaporphyrins or HPTS dye molecules embedded within breathable, hydrophobic films. Our first in human measurements reveal the devices are able to detect quick and subtle changes in tcpO2 due to local and systemic changes in blood flow of skin or deeper muscle tissue. Models to extract tissue oxygenation and oxygen consumption rate are explored.
Cutaneous pharmacokinetics (cPK) can be quantified utilizing a myriad of in vitro and in vivo approaches. However, these techniques provide macroscale cPK for long experimental durations and do not provide cPK information from the moments directly after a topical formulation application, thus missing critical product dosing insight. Furthermore, formulations are typically applied for 5-10 minutes in the clinic and then removed (purposely or accidentally), which requires a high temporal and spatial resolution estimate of the early timepoint cPK. We have developed a 3-D printed applicator to address the unmet need for early time-point cPK quantification pertinent to the clinic.
We present a wireless, wearable device to measure transcutaneous partial oxygen pressure (tcpO2) non-invasively. The device, tuned to physiological range pO2, detects changes in phosphorescence lifetime and intensity of ultra-bright metalloporphyrins embedded within breathable films. We have implemented machine learning algorithms to improve the accuracy of the measurements against changes in temperature, photobleaching, inter-device/film variations, etc. Our first in human measurements reveal the devices are able to detect quick and subtle changes in tcpO2 due to local and systemic changes in blood flow of skin or deeper muscle tissue. Models to extract tissue oxygenation and oxygen consumption rate are explored.
We have developed different portable tools based on phosphorescence lifetime and intensity measurements to be used together with syringes, needles, and catheters to measure oxygen partial pressure deep inside tissue with the aim to improve the assessment of acute compartment syndrome (ACS). Due to their portability and universality, the tools will also be useful in other hypoxia-related conditions such as vascular diseases, diabetic wounds, cancer, and traumatic injuries. We will present designs as well as results from in vivo porcine model studies.
Wearable devices have found widespread application in recent years as consumer electronics for sports and health tracking. A metric of health which is overlooked in currently available technology is the measurement of oxygen in living tissue, a key component in the cellular energy production. We report on the development of an optical wireless wearable prototype for transcutaneous oxygen monitoring based on the phosphorescence emission of a highly breathable oxygen sensing film. The device is truly wearable, weighs under 20 grams,is completely self-contained, requires no external readout electronics and is highly sensitive to oxygen in the physiological range.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.